Skip to main content
Figure 1 | BMC Health Services Research

Figure 1

From: Adjusting for geographic variation in observational comparative effectiveness studies: a case study of antipsychotics using state Medicaid data

Figure 1

Spatial Distribution of Drug Utilization Rates for A) Paliperidone Palmitate and B) Oral SGAs with Corresponding LISA Cluster Maps and Global Moran’s I Value for C) Paliperidone Palmitate and D) Oral SGAs. Note: Maps A and B were developed using Spatial Empirical Bayes (SEB) smoothing methods. All maps were developed by aggregating data to zip codes. Dark black lines indicate the boundaries of the MHSAs and light grey lines indicate county boundaries.

Back to article page